An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 77-84

  Mazari, Fayyaz Ali Khan ^a   Carradice, Daniel ^a   Rahman, Mohd Norhisham A Abdul ^a   Khan, Junaid A ^a   Mockford, Katherine ^a   Mehta, Tapan ^a   McCollum, Peter T ^a   Chetter, Ian C ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ANKLE PRESSURE; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CLINICAL INDICATOR; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; EURO QUALITY OF LIFE 5D QUESTIONNAIRE; FEMALE; FEMORAL ARTERY; FRIEDMAN TEST; HUMAN; INTERMITTENT CLAUDICATION; KINGS COLLEGE VASCU QUALITY OF LIFE QUESTIONNAIRE; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SF 6D QUESTIONNAIRE; SHORT FORM 36; TREADMILL EXERCISE; TREATMENT DURATION;

AGED; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTERIAL OCCLUSIVE DISEASES; ENGLAND; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FEMORAL ARTERY; HOSPITALS, UNIVERSITY; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; POPLITEAL ARTERY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953811013     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.01.085     Document Type: Article

References (35)

1. Fowkes F.G., Housley E., Cawood E.H., Macintyre C.C., Ruckley C.V., and Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
2. Pell J.P. Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 9 (1995) 469-472
3. Chetter I.C., Spark J.I., Dolan P., Scott D.J., and Kester R.C. Quality of life analysis in patients with lower limb ischemia: suggestions for European standardisation. Eur J Vasc Endovasc Surg 13 (1997) 597-604
4. Mehta T., Venkata Subramaniam A., Chetter I., and McCollum P. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg 31 (2006) 46-52
5. Lee H.L., Mehta T., Ray B., Heng M.S., McCollum P.T., and Chetter I.C. A nonrandomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication. Eur J Vasc Endovasc Surg 33 (2007) 202-207
6. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
7. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 (2002) 271-292
8. Ara R., and Brazier J. Predicting the Short Form-6D Preference-Based Index using the eight mean Short Form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value Health 12 (2008) 346-353
9. Brazier J., Roberts J., Tsuchiya A., and Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13 (2004) 873-884
10. Group T.E. EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16 (1990) 199-208
11. Williams A. The measurement and valuation of health: a chronicle. Discussion paper 136, Editor York Health Economics Consortium Publisher University of York. York Health Economics Consortium (ed) (1995), The University of York discussion paper 136
12. Morgan M.B., Crayford T., Murrin B., and Fraser S.C. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 33 (2001) 679-687
13. In: Swinscow T.D.V., and Campbell M.J. (Eds). Correlation and regresssion. 9th ed. (1997), BMJ Publishing Group, Southampton
14. Dumville J.C., Lee A.J., Smith F.B., and Fowkes F.G. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract 54 (2004) 826-831
15. Regensteiner J.G., Hiatt W.R., Coll J.R., Criqui M.H., Treat-Jacobson D., McDermott M.M., et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 13 (2008) 15-24
16. Hirsch A.T., Halverson S.L., Treat-Jacobson D., Hotvedt P.S., Lunzer M.M., Krook S., et al. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med 6 (2001) 87-96
17. Heidrich H., Bullinger M., Cachovan M., Creutzig A., Diehm C., Gruss J.D., et al. Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire. Med Klin (Munich) 90 12 (1995) 693-697
18. Marquis P. Evaluation of the impact of peripheral obliterative arteriopathy on quality of life. Drugs 56 Suppl 3 (1998) 25-35
19. de Graaff J.C., Ubbink D.T., Kools E.I., Chamuleau S.A., and Jacobs M.J. The impact of peripheral and coronary artery disease on health-related quality of life. Ann Vasc Surg 16 (2002) 495-500
20. de Vries M., Ouwendijk R., Kessels A.G., de Haan M.W., Flobbe K., Hunink M.G., et al. Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 41 (2005) 261-268
21. Mehta T., Venkata Subramaniam A., Chetter I., and McCollum P. Disease-specific quality of life assessment in intermittent claudication: review. Eur J Vasc Endovasc Surg 25 (2003) 202-208
22. Pell J.P., and Lee A.J. Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants. The Scottish Vascular Audit Group. Scott Med J 42 (1997) 47-48
23. Patterson R.B., Pinto B., Marcus B., Colucci A., Braun T., and Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 25 (1997) 312-318 discussion 318-9
24. Chetter I.C., Spark J.I., Scott D.J., and Kester R.C. Does angioplasty improve the quality of life for claudicants?. A prospective study. Ann Vasc Surg 13 (1999) 93-103
25. Long J., Modrall J.G., Parker B.J., Swann A., Welborn III M.B., and Anthony T. Correlation between ankle-brachial index, symptoms, and health-related quality of life in patients with peripheral vascular disease. J Vasc Surg 39 (2004) 723-727
26. Izquierdo-Porrera A.M., Gardner A.W., Bradham D.D., Montgomery P.S., Sorkin J.D., Powell C.C., et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg 41 (2005) 625-630
27. Chetter I.C., Dolan P., Spark J.I., Scott D.J., and Kester R.C. Correlating clinical indicators of lower-limb ischemia with quality of life. Cardiovasc Surg 5 (1997) 361-366
28. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database of Systematic Reviews 2008;(4):CD000990.
29. Watson C.J., Phillips D., Hands L., and Collin J. Claudication distance is poorly estimated and inappropriately measured. Br J Surg 84 (1997) 1107-1109
30. Letterstal A., Forsberg C., Olofsson P., and Wahlberg E. Risk attitudes to treatment among patients with severe intermittent claudication. J Vasc Surg 47 (2008) 988-994
31. Grieve R., Grishchenko M., and Cairns J. SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. Eur J Health Econ 10 (2009) 15-23
32. Boonen A., van der Heijde D., Landewe R., van Tubergen A., Mielants H., Dougados M., et al. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?. Ann Rheum Dis 66 (2007) 771-777
33. Ozkan U., Oguzkurt L., and Tercan F. Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease. J Vasc Interv Radiol 20 (2009) 437-441
34. Vogt M.T., Wolfson S.K., and Kuller L.H. Segmental arterial disease in the lower extremities: correlates of disease and relationship to mortality. J Clin Epidemiol 46 (1993) 1267-1276
35. Bravo Vergel Y., and Sculpher M. Quality-adjusted life years. Pract Neurol 8 (2008) 175-182